Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

NCT05148845 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500000

Enrollment

OTHER

Sponsor class

Conditions

SARS CoV 2 Infection

Interventions

BIOLOGICAL: Booster vaccine

Sponsor

Wits Health Consortium (Pty) Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]